Prostate cancer clinical trial ENZAMET has won a trifecta of prestigious awards at the 2020 Australian Clinical Trials Alliance (ACTA) Summit. In a first for [...]
Clinicians and patients across MPCCC partner health services have enthusiastically responded to the MPCCC Precision Oncology Program in 2020, and this month the program has reached [...]
The MPCCC 2019–2020 Annual Report contains a rich and exciting account of our progress over the past financial year. Central to the achievements of the [...]
The MPCCC is delighted to welcome five new community members with lived experiences of cancer to its Advisory Group, whose multidisciplinary representatives will play a [...]
Molecular profiling of solid tumours is now more accessible for people with cancer, who are being treated across south-eastern Victoria, following the establishment of the [...]
MPCCC is excited to announce the prize winners of its inaugural State-wide search for Outstanding Cancer Research and to acknowledge the highly ranked nominees with [...]
The MPCCC is seeking five community members with an experience of cancer, to contribute vital consumer and community perspective to the work of its newly [...]
During the COVID-19 pandemic, Victoria’s health care workers are likely to encounter moral distress, anxiety and regret arising from ethical challenges in cancer care. Professor [...]
Since March 2020, the MPCCC has been working closely with the Victorian Comprehensive Cancer Centre to deliver a coordinated response to the challenges posed by [...]
Monash University’s Precision Medicine research group has discovered multiple new genetic risk factors that make men susceptible to aggressive prostate cancer, in a landmark study [...]
